Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Germany's Merck Sets Out Midterm Sales Growth, Profitability Expansion Targets
02:00am, Thursday, 16'th Oct 2025
The company confirmed its 2025 guidance and is targeting annual organic sales growth in the mid-single-digit percentage range and an expansion in profitability over the medium term.
Germany's Merck tweaks mid-term healthcare unit guidance
01:04am, Thursday, 16'th Oct 2025
German pharmaceuticals and technology company Merck KGaA slightly improved its mid-term guidance for its healthcare business ahead of its capital markets day on Thursday.
Merck: A Golden Buying Opportunity
03:43pm, Wednesday, 15'th Oct 2025
Keytruda continues to dominate, driving 50% of revenue, with new approvals and delivery methods strengthening MRK's oncology leadership. The company's long-term outlook is also promising, with a full
Merck's New HIV Treatment Works As Well As Top Drug In Late Trials
12:23pm, Wednesday, 15'th Oct 2025
The relentless pursuit of innovative treatments in the pharmaceutical industry continues to reshape the landscape of chronic disease management. Merck & Co. Inc. (NYSE:MRK) on Wednesday announced addi
Merck to Acquire the Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio
08:00am, Wednesday, 15'th Oct 2025
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced the signing of a definitive agreement to acquire the chromatography business of JSR Life Sciences,
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the presentation of additional data from the Phase 3 studies of th
Merck (MRK) Declines More Than Market: Some Information for Investors
06:51pm, Tuesday, 14'th Oct 2025
In the closing of the recent trading day, Merck (MRK) stood at $84.81, denoting a -1.04% move from the preceding trading day.
Can $10,000 in Merck Stock Turn Into $50,000 by 2030?
06:15am, Tuesday, 14'th Oct 2025
Turning $10,000 into $50,000 in about five years would require a compound annual growth rate (CAGR) of almost 38%. That's an extremely tough task for any corporation, but can Merck (MRK -0.41%), a lea
Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Monday, 13'th Oct 2025
Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why Merck (MRK) is a Strong Momentum Stock
10:51am, Monday, 13'th Oct 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Merck: An Undervalued Stock In An Expensive Market
10:00am, Monday, 13'th Oct 2025
Merck has increased its dividend for 14 consecutive years. Its 10-year dividend growth rate of 5.4% is only decent. Merck increased its revenue from $39.5 billion in FY 2015 to $64.2 billion in FY 20
5 Bank of America Value 10 Dividend Picks for Q4 Fireworks
09:19am, Sunday, 12'th Oct 2025
A value stock is generally one that trades at a price lower than its fundamental value or what its performance suggests it should be worth.
Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?
01:01pm, Friday, 10'th Oct 2025
MRK's Keytruda remains its dominant growth engine and is expected to have boosted its top line in the third quarter.
High Margins, Lower Price: Is This Merck Stock's Buying Window?
09:10am, Friday, 10'th Oct 2025
Merck (MRK) stock merits your attention. Why? Because it offers monopoly-like high margins at a discounted price.
Jamie Dimon Issues Harsh Stock Market Warning – 5 of JPMorgan's Safest Dividend Stocks
03:01pm, Thursday, 09'th Oct 2025
Jamie Dimon is one of the highest-profile bankers in the world. Like Warren Buffett, David Solomon, or other Wall Street titans, when he speaks, people listen.
